Coronavirus: the pharma and medtech response

The Statista dossier
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista dossier about the pharma and medtech response to the coronavirus pandemic

This dossier presents the response of the pharmaceutical and medical device industry to the COVID-19 pandemic. It is focused on some major aspects in relation to COVID-19: treatments, vaccines, diagnostics, and ventilators. There is also a chapter dedicated to Moderna Inc., the current frontrunner in the race for the first coronavirus vaccine.

Table of contents

  • 1. Before the pandemic: pharma
    • Pharmaceutical market: worldwide revenue 2001-2019

    • Top global pharmaceutical companies based on pharma revenue 2019

    • Size of the global vaccine market by region 2014-2024

    • Leading pharmaceutical companies by global vaccine revenue 2019

    • Global anti-viral market size 2019 and 2027 forecast

    • Leading pharmaceutical companies by global anti-viral revenue 2017 and 2024

  • 2. Treatments and vaccines
    • Biotechs: duration of COVID-19 response compared to previous health threats 2003-2019

    • Leading COVID-19 drugs, therapies and vaccines in development by early results 2020

    • Number of registered COVID-19 clinical trials worldwide July 6, 2020, by region

    • Number of COVID-19 treatment vaccines in development worldwide by phase 2020

    • Top companies by COVID-19 treatment vaccines in development 2020

    • Number of COVID-19 treatment vaccine trials worldwide by phase 2020

    • Number of COVID-19 treatment vaccine trials worldwide by type 2020

    • Opinions on the development of a treatment for the coronavirus in France in 2020

    • Worldwide opinion on development of a vaccine for coronavirus Feb 9, 2020, by country

    • U.S. adults who would hypothetically get a coronavirus vaccine as of April 2020

  • 3. Focus: Moderna Inc.
    • Moderna's revenue 2016-2019

    • Moderna Inc collaboration revenue by related party 2017-2019

    • R&D costs of Moderna 2016-2019

    • R&D expenses of Moderna by type 2019

  • 4. Business impact
    • Market capitalization change in key COVID-19 firms until end-May 2020

    • Clinical trials due to COVID-19 read out March 2020 worldwide, by stage

    • Launch disruption on global pharmaceutical market due to coronavirus 2020-2025

    • Covid-19 impact: global pharma specialty excipient demand CAGR 2019-2024

    • Concern levels on possible drug supply chain disruption due to COVID-19 2020

  • 5. Before the pandemic: medtech
    • Total medtech revenue worldwide 2011-2024

    • In-vitro diagnostics market revenues worldwide 2018-2027

    • Global in vitro diagnostics market share by top medtech companies 2017 and 2024

    • Global ventilator market size 2018-2026

    • Global ventilator market size by type 2018-2026

  • 6. Ventilators and testing
    • Number of COVID-19-related EUAs for ventilators developed by company May 2020

    • Respiratory devices with potential being modified to ventilators by company 2020

    • Weekly ventilator production change in U.S. due to COVID-19 until April 2020

    • Cumulative EUAs granted to COVID-19 tests March-June 2020

    • Covid-19 tests emergency authorized by FDA 17th March 2020, by turnaround time

    • Number of COVID-19 tests carried out daily in U.S. March-June 2020

    • Rate change of COVID-19 testing in select countries from April vs. June 2020

More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!